-transparent.png){kind=logo}
Non-obese diabetic mice display a syndrome with dramatic clinical and pathological features similar to those of Type 1 (insulin-dependent) diabetes in man. Circulating autoantibodies to the surface of islet cells were demonstrated in some of these mice by a protein A radioligand assay. To produce monoclonal antibodies to islet cell surface antigens, therefore, we took the spleens of non-obese diabetic mice, transferred the spleen cells into non-immunized recipient mice, which were made immunologically incompetent by a large dose of X-irradiation, and then fused their lymphocytes with FO mouse myeloma cells. After screening the resultant hybrids, one stable hybridoma (3A4) that produced a monoclonal antibody (IgG1) specifically bound to the surface of islet cells was obtained. The purified monoclonal antibody was bound to the surface of transplantable Syrian golden hamster insulinoma cells sevenfold more than control antibody. Adsorption of the antibody on mouse spleen lymphocytes or thymocytes resulted in only a slight decrease in 125I-protein A binding to insulinoma cells. This antibody also reacted with the surface of mouse and rat islet cells, but not with that of rat spleen cells or hepatocytes. A spectrophotometric assay for peroxidase activity demonstrated that six times more peroxidase bound to insulinoma cells incubated with the antibody than to cells treated with control antibody. Furthermore, this antibody could be visually detected in the immunoenzymatic labelling of the surface of insulinoma cells. In summary, we have developed a novel method of producing monoclonal antibodies to the surface of islet cells for probing into the pathogenesis of Type 1 diabetes.
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
January 1985,
Nihon Naibunpi Gakkai zasshi,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
August 1995,
Journal of autoimmunity,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
January 1986,
Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
April 1987,
Metabolism: clinical and experimental,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
April 1984,
American journal of veterinary research,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
March 1983,
Rinsho byori. The Japanese journal of clinical pathology,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
February 1996,
Journal of autoimmunity,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
May 1983,
The Journal of protozoology,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
March 1981,
Diabetes,
K Yokono, and
K Shii, and
J Hari, and
S Yaso, and
Y Imamura, and
K Ejiri, and
K Ishihara, and
S Fujii, and
T Kazumi, and
H Taniguchi
May 2002,
Current protocols in immunology,
